Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Topic

You searched for:

Plan de Atención de Supervivencia para Terapias Inmuno-Oncológicas FECHA DE FINALIZACIÓN: RESUMEN DEL TRATAMIENTO Nombre del paciente: Oncólogo: Información de contacto: DIAGNÓSTICO Tipo de cáncer/ubicación/patología: Ej. Carcinoma poco diferenciado de la mama izquierda; Ki-67 del 30%. Fecha del diagnóstico: Estadio: I II III IV …
癌症幸存者生活是指从患者确诊癌症开始，一直持续到生命 结束之间的生活，而不论治疗结果如何。 在讨论幸存者护理规 划的背景下，幸存者通常指的是已经不再接受治疗，并且没有 癌细胞依然活跃的证据的患者。 但是，有越来越多癌症患者在 接受免疫肿瘤疗法（IO）治疗的同时还在接受肿瘤免疫疗法治 疗的，并且还持续了很长一段时间。 这份指南可以帮助您与接 受肿瘤免疫疗法治疗的患者展开合作，使他们无论是已经停 止治疗了还是仍然在治疗中，都能在身体和情绪上享有高质 量的生活 设定恰当的目标和期望值 尽早开始，确保您和将接受肿瘤免疫疗法治疗的患者在治疗 目标上保持一致。 无论是采用的是首选治疗还是排在第三位 的治疗，有些人在这一点上可能没有清晰的对预后的理解，1 他们可能会认为肿瘤免疫疗法治疗的目标是治愈，但实际上 可能并非如此。 提问: • 您是如何理解自己目前所处情况的？ • …
Immuno-Oncology Survivor Support Resources Where to find reliable information about your condition • American Cancer Society: www.cancer.org • National Cancer Institute: www.cancer.gov • American Society of Clinical Oncology: www.cancer.net • National Comprehensive Cancer Network (NCCN): www.nccn.org/patients/ • National patient advocacy organizations: [See attached for references …
Survivorship Care Plan for Immuno-Oncology Therapies Date Completed: TREATMENT SUMMARY Name of Patient: Oncologist: Contact Info: DIAGNOSIS Cancer Type/Location/Pathology: Ex. Poorly differentiated carcinoma of the left breast; ki-67 of 30% Diagnosis Date: Stage: I II III IV Not applicable TREATMENT WITH IMMUNOTHERAPY Names …
LA SUPERVIVENCIA AL CÁNCER se refiere al periodo que va desde el diagnóstico de cáncer hasta el resto de la vida de una persona, independientemente del resultado del tratamiento. En el contexto de la planificación de los cuidados de supervivencia, supervivencia significa generalmente que la persona ya no está en tratamiento y no tiene indicios de enfermedad activa. Pero hay una población creciente …
Resumen de Transición de Cuidados FECHA DE FINALIZACIÓN RESUMEN DE LA TRANSICIÓN DE CUIDADOS EN INMUNO-ONCOLOGÍA Nombre del paciente: Oncólogo: Información de contacto: DIAGNÓSTICO Tipo de cáncer/ubicación/patología: Ej. Carcinoma poco diferenciado de la mama izquierda; Ki-67 del 30%. Fecha del diagnóstico: Estadio: I II III IV …
Recursos de apoyo a los supervivientes IO - Plantilla Dónde encontrar información fiable sobre su estado Sociedad Americana contra el Cáncer: www.cancer.org/es.html Instituto Nacional de Cáncer: www.cancer.gov/espanol Sociedad Estadounidense de Oncología Clínica: www.cancer.net/es Red Nacional Integral del Cáncer: www.nccn.org/patients/ Organizaciones nacionales de defensa …
CANCER SURVIVORSHIP refers to the period starting with a cancer diagnosis through the rest of a person’s life, regardless of the outcome of treatment. In the context of survivorship care planning, survivorship generally means that the person is no longer in treatment and has no evidence of active disease. But there is a growing population of people treated with immuno-oncology (IO) therapies …
资源 –用于插入模板文件中 肿瘤免疫疗法幸存者支持资源-模板 在哪里能获取关于您疾病情况的可靠信息 美国癌症协会: www.cancer.org 国家癌症研究院：www.cancer.gov 美国临床肿瘤学会: www.cancer.net 国家综合癌症网络 (NCCN): www.nccn.org/patients/ 国家患者倡导组织: [请参阅 附件中包含的相关参考资料] 考虑根据肿瘤免疫疗法幸存者的需求进行定制 [癌症中心网站资源] 如何找到和您一样的癌症幸存者 癌症支持社区: www.cancersupportcommunity.org/find-location-near-you 癌症专属的线上或线下面对面支持小组/同行支持 [请参阅资源列表以进行定制] …
Immuno-Oncology Survivor Support Resources Where to find reliable information about your condition American Cancer Society: www.cancer.org National Cancer Institute: www.cancer.gov American Society of Clinical Oncology: www.cancer.net National Comprehensive Cancer Network (NCCN): www.nccn.org/patients/ National patient advocacy organizations: [See attached for references …
Recursos de apoyo a los supervivientes IO - Plantilla Dónde encontrar información fiable sobre su estado • Sociedad Americana contra el Cáncer: www.cancer.org/es.html • Instituto Nacional de Cáncer: www.cancer.gov/espanol • Sociedad Estadounidense de Oncología Clínica: www.cancer.net/es • Red Nacional Integral del Cáncer: www.nccn.org/patients/ • Organizaciones nacionales de defensa …
Immuno-Oncology Care Transition Summary Date Completed: TREATMENT SUMMARY Name of Patient: Oncologist: Contact Info: DIAGNOSIS Cancer Type/Location/Pathology: Ex. Poorly differentiated carcinoma of the left breast; ki-67 of 30% Diagnosis Date: Stage: I II III IV Not applicable TREATMENT WITH IMMUNOTHERAPY Surgery: …
免疫肿瘤治疗的幸存者护理计划 完成日期 治疗方案摘要 患者姓名： 肿瘤学家： 联系方式： 诊断情况 癌症类型/肿瘤位置/病理学描述：​ 例如：左乳腺恶性分化不良癌；​ ​​Ki-67表达为30% 确诊日期： 分期: ​​​​​​​​一期​​​​​​​​​​​​二期​​​​​​​​​​​​三​期​​​​​​​​​​​​四期​ ​​​​​​​​不适用 包括免疫疗法的治疗方案 使用过药物的名称: 完成日期:​ (如果仍在治疗中​，​​ 请填写不适用) 出现的副作用: •​ ​ •​ ​ •​ ​ 是否进行临床试验 ​​​​​​​是​​​​​​​​​​​​否 如果填写是，请注明开始日期-完成日期:​(如果仍在治疗中，请填现在) …
医疗护理转换摘要 完成日期: 治疗方案摘要 患者姓名: 肿瘤学家: 联系方式: 诊断情况 癌症类型/肿瘤位置/病理学描述:​ 例如：左乳腺恶性分化不良癌；​ ​​Ki-67表达为30% 确诊日期: 分期: ​​​​​​​一期​​​​​​​​​​二期​​​​​​​​​​三​期​​​​​​​​​​四期​ ​​​​​​​不适用 治疗方案 是否进行手术:​​​​​​​​​​​​是​​​​​​​​​​​​否​​​​​手术方案/手术位置/手术发现: 手术日期: 是否进行放射治疗:​​​​​​​​​​​​是​​​​​​​​​​​​否​​​​​放疗方案/放疗位置: 开始日期:​ ​ ​ 完成日期: 系统治疗​(化学治疗，靶向治疗，免疫治疗及其他):​​​​​​​​​​​​是​​​​​​​​​​​​否 使用过药物的名称: …
WSOS 2024 Sheridan Meeting Wednesday September 18, 2024 The Sheridan Inn Sheridan, WY Attendee Roster First Name Last Name Title Account Name Korrin Seavey Account Manager - Hematology BeiGene Leigh Johnson Director/Physicist Campbell County Health-Heptner Cancer Center Steve Pinckney Executive Oncology Account Manager Exelixis Melinda Weber Director of Care …
fast facts 86 OI | Vol. 39, No. 4, 2024 | accc-cancer.org 5 Ways the AMA is Fighting for Physicians in 2024 These advocacy initiatives are all part of the AMA Recovery Plan for America’s Physicians. 1. Reforming Medicare payment 2. Fixing prior authorization 3. Fighting scope creep 4. Reducing physician burnout 5. Transforming digital health. Source. AMA. 5 ways the AMA …
As part of its mission to provide the right care at the right time for the right patient, Mercy established a new Center for Precision Medicine to better serve its predominantly rural communities.
Explore the purpose and types of genetic testing, the role a genetic counselor plays in the health care system, and the growing need for genetic counselors.
The UCSF Health team streamlined the process of seeking care from a cancer specialist by introducing web self-scheduling appointments. This innovation simplified the fragmented workflows of appointment scheduling and improved patient acquisition.
With more and more patients being diagnosed with breast cancer and an improved prognosis for those living with the disease, there’s a clear need to find ways to offset high patient volumes while maintaining high-quality care for longer-term survivors.